Inhibitory Spectrum of α2-plasmin Inhibitor

α2-Plasmin inhibitor (α2PI) has been recently characterized as a fast-reacting inhibitor of plasmin in human plasma and appears to play an important role in the regulation of fibrinolysis in vivo. We have studied the effect of purified α2PI upon various proteases participating in human blood coagula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1979-04, Vol.76 (4), p.2013-2017
Hauptverfasser: Saito, Hidehiko, Goldsmith, George H., Moroi, Masaaki, Aoki, Nobuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2017
container_issue 4
container_start_page 2013
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 76
creator Saito, Hidehiko
Goldsmith, George H.
Moroi, Masaaki
Aoki, Nobuo
description α2-Plasmin inhibitor (α2PI) has been recently characterized as a fast-reacting inhibitor of plasmin in human plasma and appears to play an important role in the regulation of fibrinolysis in vivo. We have studied the effect of purified α2PI upon various proteases participating in human blood coagulation and kinin generation. At physiological concentration (50 μ g/ml), α2PI inhibited the clot-promoting and prekallikrein-activating activity of Hageman factor fragments, the amidolytic, kininogenase, and clot-promoting activities of plasma kallikrein, and the clot-promoting properties of activated plasma thromboplastin antecedent (PTA, Factor XIa) and thrombin. α2PI had minimal inhibitory effect on surface-bound activated PTA and activated Stuart factor (Factor Xa). α2PI did not inhibit the activity of activated Christmas factor (Factor IXa) or urinary kallikrein. Heparin (1.5-2.0 units/ml) did not enhnace the inhibitory function of α2PI. These results suggest that, like other plasma protease inhibitors, α2PI possesses a broad in vitro spectrum of inhibitory properties.
doi_str_mv 10.1073/pnas.76.4.2013
format Article
fullrecord <record><control><sourceid>jstor</sourceid><recordid>TN_cdi_jstor_primary_69646</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>69646</jstor_id><sourcerecordid>69646</sourcerecordid><originalsourceid>FETCH-LOGICAL-j87t-8dce3598999652e332a80aea32be8c0ca563e276550293dce60e22670b142c8a3</originalsourceid><addsrcrecordid>eNo9jbtOwzAUQD2ARCldGZjyATjc3Gtf2yOqeFSqxNDu1Y1xRaImjeIw9LP4Eb6JSiCmsxydo9RtBWUFjh6GXnLpuDQlQkUXagaATnuD5kpd59wCQLAeZup-1X80dTMdx1OxGVKcxs-uOO6L7y_Uw0Fy1_TFv3KjLvdyyGnxx7naPj9tl696_fayWj6udevdpP17TGSDDyGwxUSE4kGSENbJR4himRI6thYw0FlmSIjsoK4MRi80V3e_2Tafp7thbDoZTzsObJh-AGovP0I</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Inhibitory Spectrum of α2-plasmin Inhibitor</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>JSTOR</source><creator>Saito, Hidehiko ; Goldsmith, George H. ; Moroi, Masaaki ; Aoki, Nobuo</creator><creatorcontrib>Saito, Hidehiko ; Goldsmith, George H. ; Moroi, Masaaki ; Aoki, Nobuo</creatorcontrib><description>α2-Plasmin inhibitor (α2PI) has been recently characterized as a fast-reacting inhibitor of plasmin in human plasma and appears to play an important role in the regulation of fibrinolysis in vivo. We have studied the effect of purified α2PI upon various proteases participating in human blood coagulation and kinin generation. At physiological concentration (50 μ g/ml), α2PI inhibited the clot-promoting and prekallikrein-activating activity of Hageman factor fragments, the amidolytic, kininogenase, and clot-promoting activities of plasma kallikrein, and the clot-promoting properties of activated plasma thromboplastin antecedent (PTA, Factor XIa) and thrombin. α2PI had minimal inhibitory effect on surface-bound activated PTA and activated Stuart factor (Factor Xa). α2PI did not inhibit the activity of activated Christmas factor (Factor IXa) or urinary kallikrein. Heparin (1.5-2.0 units/ml) did not enhnace the inhibitory function of α2PI. These results suggest that, like other plasma protease inhibitors, α2PI possesses a broad in vitro spectrum of inhibitory properties.</description><identifier>ISSN: 0027-8424</identifier><identifier>DOI: 10.1073/pnas.76.4.2013</identifier><language>eng</language><publisher>National Academy of Sciences of the United States of America</publisher><subject>Albumins ; Antithrombins ; Blood coagulation ; Blood plasma ; Clotting ; Enzymes ; Gels ; Heparin ; Sodium ; Ungulates</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1979-04, Vol.76 (4), p.2013-2017</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/69646$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/69646$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27915,27916,58008,58241</link.rule.ids></links><search><creatorcontrib>Saito, Hidehiko</creatorcontrib><creatorcontrib>Goldsmith, George H.</creatorcontrib><creatorcontrib>Moroi, Masaaki</creatorcontrib><creatorcontrib>Aoki, Nobuo</creatorcontrib><title>Inhibitory Spectrum of α2-plasmin Inhibitor</title><title>Proceedings of the National Academy of Sciences - PNAS</title><description>α2-Plasmin inhibitor (α2PI) has been recently characterized as a fast-reacting inhibitor of plasmin in human plasma and appears to play an important role in the regulation of fibrinolysis in vivo. We have studied the effect of purified α2PI upon various proteases participating in human blood coagulation and kinin generation. At physiological concentration (50 μ g/ml), α2PI inhibited the clot-promoting and prekallikrein-activating activity of Hageman factor fragments, the amidolytic, kininogenase, and clot-promoting activities of plasma kallikrein, and the clot-promoting properties of activated plasma thromboplastin antecedent (PTA, Factor XIa) and thrombin. α2PI had minimal inhibitory effect on surface-bound activated PTA and activated Stuart factor (Factor Xa). α2PI did not inhibit the activity of activated Christmas factor (Factor IXa) or urinary kallikrein. Heparin (1.5-2.0 units/ml) did not enhnace the inhibitory function of α2PI. These results suggest that, like other plasma protease inhibitors, α2PI possesses a broad in vitro spectrum of inhibitory properties.</description><subject>Albumins</subject><subject>Antithrombins</subject><subject>Blood coagulation</subject><subject>Blood plasma</subject><subject>Clotting</subject><subject>Enzymes</subject><subject>Gels</subject><subject>Heparin</subject><subject>Sodium</subject><subject>Ungulates</subject><issn>0027-8424</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNo9jbtOwzAUQD2ARCldGZjyATjc3Gtf2yOqeFSqxNDu1Y1xRaImjeIw9LP4Eb6JSiCmsxydo9RtBWUFjh6GXnLpuDQlQkUXagaATnuD5kpd59wCQLAeZup-1X80dTMdx1OxGVKcxs-uOO6L7y_Uw0Fy1_TFv3KjLvdyyGnxx7naPj9tl696_fayWj6udevdpP17TGSDDyGwxUSE4kGSENbJR4himRI6thYw0FlmSIjsoK4MRi80V3e_2Tafp7thbDoZTzsObJh-AGovP0I</recordid><startdate>19790401</startdate><enddate>19790401</enddate><creator>Saito, Hidehiko</creator><creator>Goldsmith, George H.</creator><creator>Moroi, Masaaki</creator><creator>Aoki, Nobuo</creator><general>National Academy of Sciences of the United States of America</general><scope/></search><sort><creationdate>19790401</creationdate><title>Inhibitory Spectrum of α2-plasmin Inhibitor</title><author>Saito, Hidehiko ; Goldsmith, George H. ; Moroi, Masaaki ; Aoki, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j87t-8dce3598999652e332a80aea32be8c0ca563e276550293dce60e22670b142c8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Albumins</topic><topic>Antithrombins</topic><topic>Blood coagulation</topic><topic>Blood plasma</topic><topic>Clotting</topic><topic>Enzymes</topic><topic>Gels</topic><topic>Heparin</topic><topic>Sodium</topic><topic>Ungulates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saito, Hidehiko</creatorcontrib><creatorcontrib>Goldsmith, George H.</creatorcontrib><creatorcontrib>Moroi, Masaaki</creatorcontrib><creatorcontrib>Aoki, Nobuo</creatorcontrib><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saito, Hidehiko</au><au>Goldsmith, George H.</au><au>Moroi, Masaaki</au><au>Aoki, Nobuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory Spectrum of α2-plasmin Inhibitor</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><date>1979-04-01</date><risdate>1979</risdate><volume>76</volume><issue>4</issue><spage>2013</spage><epage>2017</epage><pages>2013-2017</pages><issn>0027-8424</issn><abstract>α2-Plasmin inhibitor (α2PI) has been recently characterized as a fast-reacting inhibitor of plasmin in human plasma and appears to play an important role in the regulation of fibrinolysis in vivo. We have studied the effect of purified α2PI upon various proteases participating in human blood coagulation and kinin generation. At physiological concentration (50 μ g/ml), α2PI inhibited the clot-promoting and prekallikrein-activating activity of Hageman factor fragments, the amidolytic, kininogenase, and clot-promoting activities of plasma kallikrein, and the clot-promoting properties of activated plasma thromboplastin antecedent (PTA, Factor XIa) and thrombin. α2PI had minimal inhibitory effect on surface-bound activated PTA and activated Stuart factor (Factor Xa). α2PI did not inhibit the activity of activated Christmas factor (Factor IXa) or urinary kallikrein. Heparin (1.5-2.0 units/ml) did not enhnace the inhibitory function of α2PI. These results suggest that, like other plasma protease inhibitors, α2PI possesses a broad in vitro spectrum of inhibitory properties.</abstract><pub>National Academy of Sciences of the United States of America</pub><doi>10.1073/pnas.76.4.2013</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1979-04, Vol.76 (4), p.2013-2017
issn 0027-8424
language eng
recordid cdi_jstor_primary_69646
source PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; JSTOR
subjects Albumins
Antithrombins
Blood coagulation
Blood plasma
Clotting
Enzymes
Gels
Heparin
Sodium
Ungulates
title Inhibitory Spectrum of α2-plasmin Inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A50%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20Spectrum%20of%20%CE%B12-plasmin%20Inhibitor&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Saito,%20Hidehiko&rft.date=1979-04-01&rft.volume=76&rft.issue=4&rft.spage=2013&rft.epage=2017&rft.pages=2013-2017&rft.issn=0027-8424&rft_id=info:doi/10.1073/pnas.76.4.2013&rft_dat=%3Cjstor%3E69646%3C/jstor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_jstor_id=69646&rfr_iscdi=true